Cite Filings / KURA / 0001193125-26-239481
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEFA14A

Proxy Materials

Kura Oncology, Inc. · Filed 2026-05-26 · Acc 0001193125-26-239481

Documents 1

  • DEFA14A Proxy Materials , d124531ddefa14a.htm

Around this filing

  • 2026-05-26 DEFA14A Proxy Materials
  • 2026-05-22 4 Chief Commercial Officer sold 10,000 shares at $11.00 ($110,000)
  • 2026-05-21 144 Sale of Securities
  • 2026-05-20 4 Chief Operating Officer sold 2,257 shares at $9.08 ($20,483)
  • 2026-05-20 4 Chief Commercial Officer sold 339 shares at $9.21 ($3,122)
  • 2026-05-20 4 Chief Legal Officer sold 2,256 shares at $9.38 ($21,160)
  • 2026-04-10 DEFA14A Proxy Materials

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d124531ddefa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…